GoodRx (GDRX) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does GoodRx (GDRX) do?
GoodRx Holdings Inc (GDRX) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Operates a digital platform that provides prescription drug discount cards and comparison pricing tools. Aggregates prescription drug prices across tens of thousands of pharmacies to offer digital discount coupons. It is worth $1.03B on the market and sold $786.46M over the last year.
- Market cap
- $1.03B
- P/E ratio
- 64.1×
- Annual sales
- $786.46M
- Sector
- Healthcare
- Industry
- Health Information Services
- Brief updated
- Nov 13, 2026
Brands and businesses behind GDRX
- VitaCare: Provides digital pharmacy services that help patients access and afford specialized therapies through manufacturer copay programs.
GDRX’s flags, in plain English
Each flag is a number from GoodRx’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.
Wide Gross Margin
Gross margin of 79.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Cheap on Cash Flow
Priced at 5.2 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.
Insiders Hold
Insiders own 74.2% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Priced for Perfection
Priced at 64.1 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
1 more risk note open with the free trial. Try it free for 7 days.
Questions about GDRX
How big is GoodRx?
GoodRx’s market cap is $1.03B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $786.46M: what customers paid the company over the last year, before any costs.
What is GDRX’s P/E ratio?
GDRX’s P/E ratio is 64.1×. Investors pay about 64.1 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with GDRX?
A pending thirty-two million dollar data privacy class action settlement creates immediate administrative costs and legal exposure. That is one risk on GoodRx’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From GoodRx’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. GDRX’s filings on SEC.gov. The Margin Monkey is research, not advice.
